Healthcare provider profile · identity verified

Jose G Guzman, MD

Allopathic & Osteopathic Physicians|Family Medicine · BRODHEADSVLLE, PA · NPI 1033472857

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Jose G Guzman, MD received $145.02 in general payments during 2025 across 4 reported records.

Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 98 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Rybelsus by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$145.02

4 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$145.02	100.0%	4	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$145.02	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$121.16	2	2025
Source payment records 2025-06-16 · Novo Nordisk Inc · $7.76 · Open Payments source 2025-06-25 · Novo Nordisk Inc · $113.40 · Open Payments source
Wegovy Normalized: wegovy	Drug	Novo Nordisk Inc	$9.04	1	2025
Source payment records 2025-02-03 · Novo Nordisk Inc · $9.04 · Open Payments source
Rybelsus Normalized: rybelsus	Drug	Novo Nordisk Inc	$7.76	1	2025
Source payment records 2025-06-16 · Novo Nordisk Inc · $7.76 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
Ozempic ozempic	2025	Ozempic	2024	98	exact normalized	Medicare Part D
Rybelsus rybelsus	2025	Rybelsus	2024	24 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	98	23
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	24	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	728	213
Amlodipine Besylate	Amlodipine Besylate	535	142
Lisinopril	Lisinopril	442	113
Metformin Hcl	Metformin Hcl	357	98
Levothyroxine Sodium	Levothyroxine Sodium	347	83
Losartan Potassium	Losartan Potassium	319	81
Pantoprazole Sodium	Pantoprazole Sodium	272	75
Hydrochlorothiazide	Hydrochlorothiazide	268	72
Gabapentin	Gabapentin	265	66
Simvastatin	Simvastatin	259	66
Albuterol Sulfate Hfa	Albuterol Sulfate	192	49
Metoprolol Succinate	Metoprolol Succinate	188	55
Omeprazole	Omeprazole	187	47
Fluticasone Propionate	Fluticasone Propionate	185	75
Alprazolam	Alprazolam	184	39
Jardiance	Empagliflozin	174	40
Tramadol Hcl	Tramadol Hcl	169	41
Montelukast Sodium	Montelukast Sodium	164	47
Rosuvastatin Calcium	Rosuvastatin Calcium	161	42
Metoprolol Tartrate	Metoprolol Tartrate	149	40
Lorazepam	Lorazepam	144	36
Ibuprofen	Ibuprofen	134	45
Tamsulosin Hcl	Tamsulosin Hcl	133	40
Trazodone Hcl	Trazodone Hcl	132	33
Eliquis	Apixaban	131	32
Oxycodone Hcl	Oxycodone Hcl	128	15
Allopurinol	Allopurinol	118	32
Zolpidem Tartrate	Zolpidem Tartrate	111	32
Sertraline Hcl	Sertraline Hcl	108	26
Warfarin Sodium	Warfarin Sodium	104	16
Furosemide	Furosemide	103	36
Carvedilol	Carvedilol	100	25
Ozempic	Semaglutide	98	23
Glipizide	Glipizide	92	26
Escitalopram Oxalate	Escitalopram Oxalate	90	27
Mounjaro	Tirzepatide	89	24
Famotidine	Famotidine	81	30
Potassium Chloride	Potassium Chloride	81	30
Pravastatin Sodium	Pravastatin Sodium	77	24
Spironolactone	Spironolactone	73	16
Fluoxetine Hcl	Fluoxetine Hcl	69	12
Clopidogrel	Clopidogrel Bisulfate	68	19
Prednisone	Prednisone	67	45
Duloxetine Hcl	Duloxetine Hcl	66	19
Pregabalin	Pregabalin	66	11
Alendronate Sodium	Alendronate Sodium	64	24
Triamcinolone Acetonide	Triamcinolone Acetonide	64	34
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	63	50
Diclofenac Sodium	Diclofenac Sodium	63	21
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	63	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	56	11
Citalopram Hbr	Citalopram Hydrobromide	54	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	54	suppressed
Diazepam	Diazepam	52	suppressed
Meloxicam	Meloxicam	51	19
Doxycycline Monohydrate	Doxycycline Monohydrate	50	41
Methocarbamol	Methocarbamol	50	11
Venlafaxine Hcl Er	Venlafaxine Hcl	50	12
Bupropion Xl	Bupropion Hcl	49	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	15
Baclofen	Baclofen	48	13
Glimepiride	Glimepiride	48	15
Januvia	Sitagliptin Phosphate	48	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	13
Hydralazine Hcl	Hydralazine Hcl	45	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	44	34
Fluconazole	Fluconazole	43	23
Mirtazapine	Mirtazapine	43	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	43	16
Ezetimibe	Ezetimibe	41	13
Chlorthalidone	Chlorthalidone	39	12
Clonazepam	Clonazepam	39	suppressed
Tizanidine Hcl	Tizanidine Hcl	38	16
Ventolin Hfa	Albuterol Sulfate	38	suppressed
Valsartan	Valsartan	36	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	35	14
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	17
Meclizine Hcl	Meclizine Hcl	32	14
Trulicity	Dulaglutide	32	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	suppressed
Azelastine Hcl	Azelastine Hcl	30	14
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Enalapril Maleate	Enalapril Maleate	30	suppressed
Finasteride	Finasteride	30	11
Metformin Hcl Er	Metformin Hcl	30	11
Atenolol	Atenolol	29	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Irbesartan	Irbesartan	29	suppressed
Novolog Flexpen	Insulin Aspart	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	27	suppressed
Ramipril	Ramipril	27	suppressed
Terbinafine Hcl	Terbinafine Hcl	27	18
Xarelto	Rivaroxaban	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	12
Fenofibrate	Fenofibrate	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Rybelsus	Semaglutide	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Torsemide	Torsemide	22	suppressed
Naproxen	Naproxen	21	suppressed
Varenicline Tartrate	Varenicline Tartrate	21	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Tradjenta	Linagliptin	20	suppressed
Latanoprost	Latanoprost	19	suppressed
Prazosin Hcl	Prazosin Hcl	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Repaglinide	Repaglinide	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Azithromycin	Azithromycin	14	12
Fenofibrate	Fenofibrate,micronized	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Armour Thyroid	Thyroid,pork	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Nucynta	Tapentadol Hcl	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nystatin	Nystatin	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Temazepam	Temazepam	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Estradiol	Estradiol	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$145.02 · 4 records	Novo Nordisk Inc	Ozempic, Rybelsus, Wegovy	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Ozempic play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error